MedPath
TGA Approval

BRAFTOVI encorafenib 50 mg capsule blister pack (295764)

295764

BRAFTOVI encorafenib 50 mg capsule blister pack

Pierre Fabre Australia Pty Ltd

January 3, 2019

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-01463-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01022-1

Active Ingredients

encorafenib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.